SCHEMBL13143891

SCHEMBL13143891

CC1N(C)c2ccccc2N1c1ccccc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 4/20 0.41
▸ GAA P10253 3/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ HSD17B10 Q99714 3/20 0.37
▸ HIF1A Q16665 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ PTPN2 P17706 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ GPR3 P46089 1/20 0.35
▸ IDO1 P14902 1/20 0.34
▸ LMNA P02545 3/20 0.33
▸ EGFR P00533 2/20 0.33
▸ NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11995104 0.78 ALDH1A1 (0.42) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL12349380 0.78 ALDH1A1 (0.42) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL9891023 0.78 ALDH1A1 (0.42) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL16420322 0.78 KDM4E (0.47) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL30353863 0.76 GAA (0.62) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL1049325 0.76 GAA (0.62) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL24398363 0.76 GAA (0.44) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL16711487 0.76 GAA (0.44) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL11941264 0.76 GAA (0.44) KDM4EALDH1A1HPGDGAAALOX12
SCHEMBL25445409 0.76 MGLL (0.43) KDM4EALDH1A1HPGDGAAALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795430-B2 Reversibly reducible metal complexes as electron transporting materials for OLEDs THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2010-09-14 — — US disclosed
US-7795430-B2 Reversibly reducible metal complexes as electron transporting materials for OLEDs THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2010-09-14 — — US disclosed
US-20090306385-A1 REVERSIBLY REDUCIBLE METAL COMPLEXES AS ELECTRON TRANSPORTING MATERIALS FOR OLEDS WALTERS ROBERT 2009-12-10 — — US disclosed
US-20090306385-A1 REVERSIBLY REDUCIBLE METAL COMPLEXES AS ELECTRON TRANSPORTING MATERIALS FOR OLEDS WALTERS ROBERT 2009-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306385-A1 REVERSIBLY REDUCIBLE METAL COMPLEXES AS ELECTRON TRANSPORTING MATERIALS FOR OLEDS OXA1L, ETFA, OCIAD1 KDM4E 3677/4885ALDH1A1 589/4885HPGD 1099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback